Long term safety and efficacy of the yukon choice flex sirolimus-eluting coronary stent- a real world data from india

Long term safety and efficacy of the yukon choice flex sirolimus-eluting coronary stent- a real world data from india

Bibliographic Details
Main Authors:	Basant Kumar Sourabh Agstam, Jyothi Vijay, Neelam Dahiya
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	Indian Heart Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483220303126

Similar Items

Safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent in an all-comers population cohort
by: E. Xhepa, et al.
Published: (2014-05-01)

Clinical results of indigenous biodegradable polymer sirolimus eluting Yukon Choice Flex stent in all comer patients with coronary artery disease
by: P. Nayak, et al.
Published: (2015-12-01)

Coronary angioplasty in unprotected left main disease with indigenous sirolinus eluting biodegradable polymer Yukon choice flex stent
by: S. Lahiri, et al.
Published: (2015-12-01)

Sirolimus-eluting coronary stents: a review
by: Alexandre Abizaid
Published: (2007-05-01)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
by: Alaide Chieffo, et al.
Published: (2007-09-01)

Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
by: Alain Guidon, et al.
Published: (2008-01-01)

Sirolimus-eluting stents: A small piece of the story of percutaneous coronary intervention
by: Jorge Ferreira
Published: (2020-11-01)

Sirolimus-eluting stents: A small piece of the story of percutaneous coronary intervention
by: Jorge Ferreira
Published: (2020-11-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Open-labeled randomized controlled trial to evaluate the 1-year clinical outcomes of polymer-free sirolimus-eluting coronary stents as compared with biodegradable polymer-based sirolimus-eluting coronary stents
by: Sunitha Viswanathan, et al.
Published: (2018-12-01)

A modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
by: А. Н. Кудряшов, et al.
Published: (2017-04-01)

Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
by: Maeng Michael, et al.
Published: (2012-10-01)

Preliminary Evaluation of Clinical and Angiographic Outcomes with Biodegradable Polymer Coated Sirolimus-Eluting Stent in De Novo Coronary Artery Disease: Results of the MANIPAL-FLEX Study
by: Ranjan Shetty, et al.
Published: (2016-01-01)

Treatment of long coronary lesions with single stent: BioMime Morph sirolimus-eluting tapered coronary stent system
by: Suresh V Patted
Published: (2018-01-01)

Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stents.
by: Matthijs A Velders, et al.
Published: (2014-01-01)

Twelve-month clinical outcomes of sirolimus-eluting stent in coronary artery disease: An experience in real-world Indian patients
by: Srikanth Nathani, et al.
Published: (2020-11-01)

In vivo assessment of stent recoil of biodegradable polymer-coated cobalt–chromium sirolimus-eluting coronary stent system
by: Atul D. Abhyankar, et al.
Published: (2012-11-01)

Evaluation of Clinical Outcomes in Patients Undergoing Dual Vessel Percutaneous Coronary Intervention Using Sirolimus-Eluting Coronary Stent System in India
by: Prakash Chandwani, et al.
Published: (2015-02-01)

EFFICACY OF SIROLIMUS ELUTING STENTS IMPLANTATION IN DIFFUSE (LONG AND EXTREMELY LONG) CORONARY ATHEROSCLEROTIC LESIONS
by: A. M. Babunashvili, et al.
Published: (2017-10-01)

Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries
by: Christian Sperling, et al.
Published: (2019-02-01)

Long-term effectiveness and safety of sirolimus drug-eluting stents
by: Bikkina M, et al.
Published: (2011-08-01)

Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem
by: Igor Kranjec, et al.
Published: (2009-01-01)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
by: Matthijs A. Velders, et al.
Published: (2013-01-01)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
by: Ryota Kakizaki, et al.
Published: (2020-10-01)

Study to assess clinical outcomes of an everolimus-eluting stent (EES) versus a sirolimus-eluting stent (SES)
by: Amit Madaan, et al.
Published: (2015-12-01)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents.
by: Matthijs A. Velders, et al.
Published: (2013-01-01)

Ten-year survival of patients undergoing coronary angioplasty with first-generation sirolimus-eluting stents and bare-metal stents
by: Nelson Vale, et al.
Published: (2020-11-01)

Ten-year survival of patients undergoing coronary angioplasty with first-generation sirolimus-eluting stents and bare-metal stents
by: Nelson Vale, et al.
Published: (2020-11-01)

Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
by: Xinlin Zhang, et al.
Published: (2014-01-01)

Comparison of everolimus-eluting and sirolimus-eluting coronary stents in 1-year clinical and angiographic follow-up: A retrospective cohort study
by: Ankur Gupta, et al.
Published: (2015-12-01)

Optimized sirolimus-eluting stent by coating asymmetrically with biodegradable and cytocompatible polymers
by: Seong Min Kim, et al.
Published: (2016-02-01)

Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
by: Thim Troels, et al.
Published: (2012-03-01)

Long-term clinical results of coronary angioplasty with sirolimus-eluting stents in patients with Type 2 diabetes mellitus
by: K. N. Petrova, et al.
Published: (2008-10-01)

P8.13 CORONARY IMPLANTATION OF SIROLIMUS-ELUTING STENT IMPAIRS THE PERIPHERAL VASCULAR COMPLIANCE IN PATIENT WITH CORONARY ARTERY DISEASE
by: M. Vatrano, et al.
Published: (2009-12-01)

Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience.
by: Pankaj Jariwala, MD, DNB, DNB, MNAMS, FICPS, FACC, FSCAI, Fellowship in Interventional Cardiology (ICPS, Paris, France), et al.
Published: (2021-01-01)

The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence
by: Alberto Chisari, et al.
Published: (2016-09-01)

Prospective rAndomized, single-blind, mulTicenter study of sirolimus-eluting coRonary stent “Calypso” vs everolimus-eluting cOronary stenT “XiencePrime”: results of the PATRIOT trial
by: A. A. Prokhorikhin, et al.
Published: (2017-11-01)

Interim Results of the Basket of Real-World Randomised Clinical PRISM Trials for M’Sure-S, a Next-Generation Sirolimus-Eluting Stent, Versus Eliminator, an Everolimus-Eluting Stent
by: Marc Silvestri, et al.
Published: (2018-09-01)

Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent
by: Anurag Polavarapu, et al.
Published: (2015-01-01)

A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native Coronary Arteries IV study
by: Teeuwen Koen, et al.
Published: (2012-12-01)

Cannot write session to /tmp/vufind_sessions/sess_lifgud29p3rarq0dojjulfn78g